Astrana Health (NASDAQ:ASTH – Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37), Zacks reports. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%.
Astrana Health Stock Down 1.2 %
ASTH traded down $0.42 on Thursday, reaching $34.68. The company’s stock had a trading volume of 235,334 shares, compared to its average volume of 335,297. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. Astrana Health has a fifty-two week low of $29.08 and a fifty-two week high of $63.20. The stock has a 50 day moving average of $35.01 and a two-hundred day moving average of $44.72. The company has a market capitalization of $1.95 billion, a price-to-earnings ratio of 26.68, a P/E/G ratio of 1.37 and a beta of 1.20.
Wall Street Analysts Forecast Growth
Several analysts recently issued reports on the stock. Stifel Nicolaus reduced their price objective on shares of Astrana Health from $70.00 to $56.00 and set a “buy” rating on the stock in a report on Thursday, February 20th. Macquarie raised Astrana Health to a “hold” rating in a research report on Monday, December 16th. Robert W. Baird lifted their price objective on Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th. Finally, Truist Financial lowered their target price on Astrana Health from $59.00 to $50.00 and set a “buy” rating for the company in a report on Monday, January 13th. Two investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Astrana Health presently has an average rating of “Moderate Buy” and a consensus price target of $65.60.
About Astrana Health
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Recommended Stories
- Five stocks we like better than Astrana Health
- The How And Why of Investing in Oil Stocks
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.